Profil
Leah Makley was the founder of Viewpoint Therapeutics, Inc., founded in 2014, and held the title of Chief Executive Officer.
Dr. Makley currently holds the positions of Chief Operations Officer at MBC Biolabs and Chief Operating Officer at Deciduous Therapeutics, Inc. since 2022.
Dr. Makley completed an undergraduate degree at the University of Dayton in 2009 and a doctorate at the University of Michigan in 2014.
Aktive Positionen von Leah Makley
| Unternehmen | Position | Beginn |
|---|---|---|
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Geschäftsführer | 01.02.2022 |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Geschäftsführer | - |
Ehemalige bekannte Positionen von Leah Makley
| Unternehmen | Position | Ende |
|---|---|---|
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Vorstandsvorsitzender | 01.02.2022 |
Ausbildung von Leah Makley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Commercial Services |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
















